Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

FMP2.1 Trial in Bandiagara, Mali

This study has been completed.
Sponsor:
Collaborators:
Walter Reed Army Institute of Research (WRAIR)
GlaxoSmithKline
University of Maryland
Information provided by (Responsible Party):
U.S. Army Medical Research and Materiel Command
ClinicalTrials.gov Identifier:
NCT00349713
First received: July 6, 2006
Last updated: June 19, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)